Cambridge Investment Research Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Cambridge Investment Research Advisors's BCAT Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 2% in Q2 2026, buying an estimated $69.1K and bringing the position to 234,106 shares worth $3.73M. The position accounts for 0.01% of the portfolio, ranked #1218.
Cambridge Investment Research Advisors first reported a position in BCAT in Q4 2020 and has held it in 20 quarters since. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Cambridge Investment Research Advisors held 234,106 shares of BlackRock Capital Allocation Term Trust worth $3.73M as of Q2 2026.
- Cambridge Investment Research Advisors bought 4,497 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $69.1K.
- BlackRock Capital Allocation Term Trust made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1218 holding.
- Cambridge Investment Research Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q4 2020 and has held it in 20 quarters since.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.